MIR514A2: A Potential Drug Target and Biomarker (G574517)

Target Name: MIR514A2

NCBI ID: G574517

MIR514A2: A Potential Drug Target and Biomarker

MicroRNA-514a-5p (MIR514A2) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. MIR514A2 is a key regulator of the immune response and has been shown to play a critical role in the regulation of inflammation and autoimmune diseases.

The discovery of MIR514A2 as a potential drug target comes from a study by the researchers at the University of California, San Diego, led by Dr. Feng Yan. The study, published in the journal Nature Medicine in 2013, identified MIR514A2 as a potential drug target in cancer cells and use it to develop a new cancer treatment strategy.

The researchers found that MIR514A2 was highly expressed in human cancer tissues and was associated with cancer progression. They also found that MIR514A2 was a good predictor of cancer patient survival, with higher expression of MIR514A2 associated with poor prognosis.

In addition to its potential as a cancer drug target, MIR514A2 has also been identified as a potential biomarker for cancer. The researchers found that MIR514A2 was significantly altered in human cancer tissues and was associated with the development of cancer. They also found that MIR514A2 was a good predictor of cancer patient survival, with higher expression of MIR514A2 associated with poor prognosis.

MIR514A2 is a small non-coding RNA molecule that plays a critical role in the regulation of the immune response and has been shown to be involved in the development of cancer. The discovery of MIR514A2 as a potential drug target and biomarker has the potential to lead to new cancer treatments and therapies.

While further research is needed to fully understand the role of MIR514A2 in cancer, the potential drug target and biomarker is an exciting finding that has the potential to lead to new treatments for cancer. With further research, MIR514A2 may be able to be used as a valuable tool for the development of new cancer treatments.

Protein Name: MicroRNA 514a-2

More Common Targets